To further investigate the essentiality of compensatory cyclin D2 upregulation in the observed trametinib resistance among MM cells, the trametinib-sensitive M5 cell line was engineered to express a Tet-on inducible cyclin D2 (M5D2). The gene discussed is CCND2; the disease is Miyoshi myopathy.